Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation
|
SUTRO BIOPHARMA, INC. (STRO)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/11/2023 |
4
| Chung Jane (Chief Commercial Officer) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Paid exercise price by delivering 6,483 shares
@ $4.22, valued at
$27.4k
Exercised 18,750 restricted stock units
@ $0 |
|
07/13/2023 |
4
| Vasquez Nicki (Chief Port. Strat & Alnce Ofcr) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Paid exercise price by delivering 1,123 shares
@ $4.7, valued at
$5.3k
Exercised 3,250 restricted stock units
@ $0 |
|
06/29/2023 |
4
| Petree Daniel H (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Gifted 18,409 shares
@ $0 Gifted 18,409 shares
@ $0 |
|
06/12/2023 |
4
| Hunter Heidi (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Granted 25,000 options to buy
@ $5.12, valued at
$128k
|
|
06/12/2023 |
4
| Wigginton Jon Marc (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Granted 25,000 options to buy
@ $5.12, valued at
$128k
|
|
06/12/2023 |
4
| Petree Daniel H (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Granted 25,000 options to buy
@ $5.12, valued at
$128k
|
|
06/12/2023 |
4
| PANEK JAMES P (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Granted 25,000 options to buy
@ $5.12, valued at
$128k
|
|
06/12/2023 |
4
| MATSUI CONNIE (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Granted 25,000 options to buy
@ $5.12, valued at
$128k
|
|
06/12/2023 |
4
| Lobacki Joseph M (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Granted 25,000 options to buy
@ $5.12, valued at
$128k
|
|
06/12/2023 |
4
| Freund John Gordon (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Granted 25,000 options to buy
@ $5.12, valued at
$128k
|
|
06/12/2023 |
4
| Dybbs Michael (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Granted 25,000 options to buy
@ $5.12, valued at
$128k
|
|
05/02/2023 |
4
| Srinivasan Venkatesh (Chief Tech Op Officer) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Granted 7,500 options to buy
@ $4.58, valued at
$34.4k
Granted 10,000 restricted stock units
@ $0 |
|
05/02/2023 |
3
| Srinivasan Venkatesh (Chief Tech Op Officer) has filed a Form 3 on SUTRO BIOPHARMA, INC. |
04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/17/2023 |
4
| Borgman Anne Elizabeth (Chief Medical Officer) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Granted 175,000 options to buy
@ $5.4, valued at
$945k
Granted 150,000 restricted stock units
@ $0 |
|
03/07/2023 |
4
| Shtylla Brunilda (Chief Business Officer) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Paid exercise price by delivering 4,536 shares
@ $5.79, valued at
$26.3k
Granted 40,000 options to buy
@ $5.79, valued at
$231.6k
Granted 27,500 restricted stock units
@ $0 Exercised 6,750 restricted stock units
@ $0 Exercised 4,375 restricted stock units
@ $0 |
|
03/07/2023 |
3
| Shtylla Brunilda (Chief Business Officer) has filed a Form 3 on SUTRO BIOPHARMA, INC. |
03/07/2023 |
3
| Borgman Anne Elizabeth (Chief Medical Officer) has filed a Form 3 on SUTRO BIOPHARMA, INC. |
03/07/2023 |
4
| Vasquez Nicki (Chief Port. Strat & Alnce Ofcr) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Paid exercise price by delivering 4,990 shares
@ $5.79, valued at
$28.9k
Granted 35,000 options to buy
@ $5.79, valued at
$202.7k
Granted 25,000 restricted stock units
@ $0 Exercised 6,750 restricted stock units
@ $0 Exercised 5,500 restricted stock units
@ $0 |
|
03/07/2023 |
4
| Hallam Trevor (Pres. Rsrch & Cf. Sctific Ofcr) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Paid exercise price by delivering 7,717 shares
@ $5.79, valued at
$44.7k
Granted 50,000 options to buy
@ $5.79, valued at
$289.5k
Granted 40,000 restricted stock units
@ $0 Exercised 9,750 restricted stock units
@ $0 Exercised 12,500 restricted stock units
@ $0 |
|
03/07/2023 |
4
| FITZPATRICK LINDA A (Chief People & Comm. Officer) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Paid exercise price by delivering 6,395 shares
@ $5.79, valued at
$37k
Granted 40,000 options to buy
@ $5.79, valued at
$231.6k
Granted 27,500 restricted stock units
@ $0 Exercised 9,125 restricted stock units
@ $0 Exercised 8,750 restricted stock units
@ $0 |
|
03/07/2023 |
4
| Chung Jane (Chief Commercial Officer) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Paid exercise price by delivering 3,211 shares
@ $5.79, valued at
$18.6k
Granted 40,000 options to buy
@ $5.79, valued at
$231.6k
Granted 27,500 restricted stock units
@ $0 Exercised 7,875 restricted stock units
@ $0 |
|
03/07/2023 |
4
| Shabbir Anik (Chief Technical Ops. Officer) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Paid exercise price by delivering 6,222 shares
@ $5.79, valued at
$36k
Granted 40,000 restricted stock units
@ $0 Exercised 7,875 restricted stock units
@ $0 Exercised 8,750 restricted stock units
@ $0 |
|
03/07/2023 |
4
| ALBINI EDWARD C (CFO and Secretary) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Paid exercise price by delivering 6,588 shares
@ $5.79, valued at
$38.1k
Granted 47,000 options to buy
@ $5.79, valued at
$272.1k
Granted 31,500 restricted stock units
@ $0 Exercised 9,125 restricted stock units
@ $0 Exercised 8,750 restricted stock units
@ $0 |
|
02/14/2023 |
4
| ALBINI EDWARD C (CFO and Secretary) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Exercised 45,698 options to buy
@ $5.808, valued at
$265.4k
|
|
01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/10/2022 |
4
| Chung Jane (Chief Commercial Officer) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Paid exercise price by delivering 6,483 shares
@ $6.6, valued at
$42.8k
Exercised 18,750 restricted stock units
@ $0 |
|
07/13/2022 |
4
| Vasquez Nicki (Chief Port. Strat & Alnce Ofcr) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Paid exercise price by delivering 1,123 shares
@ $6.08, valued at
$6.8k
Exercised 3,250 restricted stock units
@ $0 |
|
06/08/2022 |
4
| Wigginton Jon Marc (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns:
| Granted 18,500 options to buy
@ $4.44, valued at
$82.1k
|
|
|
|
|